Impact of body weight-based dosing of palonosetron and ondansetron on postoperative nausea and vomiting following laparoscopic sleeve gastrectomy: a randomized, double-blind study
CONCLUSIONS: The use of palonosetron significantly reduced the incidence of PONV following laparoscopic sleeve gastrectomy. There was a significant improvement in the scores of Functional Living Index-Emesis in patients using palonosetron.PMID:36827206 | DOI:10.1080/00015458.2023.2184939 (Source: Acta Chirurgica Belgica)
Source: Acta Chirurgica Belgica - February 24, 2023 Category: Surgery Authors: B üşra Burcu Nadir Adnan Hac ım Ozan Caliskan Serdar Demirgan Talar Vartanoglu Aktokmakyan Serhat Meric Tomris Duymaz Onder Karabay Ali Solmaz Source Type: research
Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia
CONCLUSION: Reinforcing the analgesic protocol by combining non-opioid and opioid molecules reduces perioperative pain in patients undergoing cTACE for HCC.PMID:36805801 | DOI:10.1016/j.diii.2022.10.013 (Source: Cancer Control)
Source: Cancer Control - February 22, 2023 Category: Cancer & Oncology Authors: Quentin Vanderbecq Jules Gr égory Jeremy Dana Marco Dioguardi Burgio Lorenzo Garzelli Lucas Raynaud S ébastien Frémy Luisa Paulatto Mohamed Bouattour Juliette Kavafyan-Lasserre Val érie Vilgrain Maxime Ronot Source Type: research
Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting
CONCLUSION: These results do not conclusively support the superiority of either regimen for patients with breast cancer who are receiving AC.PMID:36810240 | DOI:10.12809/hkmj209182 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - February 22, 2023 Category: General Medicine Authors: C Ch Yip L Li T K H Lau V T C Chan C C H Kwok J J S Suen F K F Mo W Yeo Source Type: research
Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting
CONCLUSION: These results do not conclusively support the superiority of either regimen for patients with breast cancer who are receiving AC.PMID:36810240 | DOI:10.12809/hkmj209182 (Source: Hong Kong Med J)
Source: Hong Kong Med J - February 22, 2023 Category: General Medicine Authors: C Ch Yip L Li T K H Lau V T C Chan C C H Kwok J J S Suen F K F Mo W Yeo Source Type: research
Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting
CONCLUSION: These results do not conclusively support the superiority of either regimen for patients with breast cancer who are receiving AC.PMID:36810240 | DOI:10.12809/hkmj209182 (Source: Hong Kong Med J)
Source: Hong Kong Med J - February 22, 2023 Category: General Medicine Authors: C Ch Yip L Li T K H Lau V T C Chan C C H Kwok J J S Suen F K F Mo W Yeo Source Type: research
Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting
CONCLUSION: These results do not conclusively support the superiority of either regimen for patients with breast cancer who are receiving AC.PMID:36810240 | DOI:10.12809/hkmj209182 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - February 22, 2023 Category: General Medicine Authors: C Ch Yip L Li T K H Lau V T C Chan C C H Kwok J J S Suen F K F Mo W Yeo Source Type: research
